CVSA Covista Inc. Common Shares
NYSE · Diversified Consumer Services · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026CVSA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
CVSA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
| Ex-Datum | Split | Typ |
|---|---|---|
| 22. Juni 1998 | 2-for-1 | Vorwärts |
| 19. Dezember 1996 | 2-for-1 | Vorwärts |
| 22. Juni 1995 | 2-for-1 | Vorwärts |
Über Covista Inc. Common Shares Unternehmensübersicht von Wikipedia
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026.
History
DeVry Inc. was created in 1987 with the merger of DeVry Institute of Technology (DIT) and the Keller Graduate School of Management. DIT was established in Chicago as the DeForest Training School in 1931 and was acquired by Bell & Howell in 1967. Keller was started by two DIT teachers in 1973; the company acquired DIT from Bell & Howell in 1987. DeVry Inc. went public in 1991, moved to the New York Stock Exchange in 1995, and became known as DeVry Education Group in 2013. The company was previously based in Downers Grove, Illinois.
In 2012, the company moved 150 jobs from its campus in Roscoe Village to a new office in Chicago's West Loop. The company had additional offices in Oak Brook, as of 2013. In 2015, the company opened another office in the West Loop, after the city approved a $1 million subsidy for the company in the form of tax increment financing in 2012.
In November 2013, DeVry Inc. was renamed DeVry Education Group.
Adtalem agreed to purchase Walden University for approximately $1.5 billion in September 2020. The agreement required approval by the U.S. Department of Education and the Higher Learning Commission. When the deal closed in August 2021, Adtalem became the largest provider of graduate and undergraduate degrees in nursing.
Rebranding from DeVry Education Group to Adtalem Global Education
Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017 and began the process to sell off DeVry University and Keller Graduate School of Management later that year. Industry analysts characterized the move as an effort to move on from DeVry's legal, financial and reputational challenges.
The company's headquarters were later relocated from Downers Grove to 500 West Monroe Street in the West Loop Gate. In 2024, Crain's Chicago Business said Adtalem had become "the largest health care educator in the nation during a post-COVID period in which the health care sector has faced severe labor shortages".
Operations
Campuses and enrollment
Adtalem's institutions operated approximately 130 campuses globally in 2018. Twelve of the 90 U.S. campuses were located in Illinois. In 2020, Adtalem's businesses operated 26 campuses in four countries and fifteen U.S. states. Approximately 90,000 students attended schools with a combined 6,100 faculty members. As of 2021, approximately 82 percent of the 140,000 students enrolled at Adtalem schools learned via distance education. In 2022, Adtalem operated 27 campuses and offered courses in 209 countries and territories.
In 2026, Covista and Advocate Health partnered to create a pipeline to place nursing graduates in the latter's hospitals. The collaboration is focused on Chamberlain University and seeks to address the nation's nursing shortage.
Leadership
Stephen Beard, who was previously Adtalem's chief operating officer, became the chief executive officer (CEO) in 2021. He was appointed the chair of the board of directors in November 2024, succeeding Michael W. Malafronte. Beard was included in Time magazine's 2025 "Time100 Health" list of influential people in the healthcare industry.
Chris Begley was the board chair in 2016. Daniel Hamburger and Lisa Wardell have previously held the CEO role. Wardell was appointed in 2016. She was the only Black woman to lead a Fortune 1000 company in 2018, according to Crain's Chicago Business. Wardell was also the board chair in 2019. In 2021, an analysis by the University of Illinois Urbana-Champaign ranked Adtalem in the top five Illinois-based public firms for both gender and racial diversity on the board.
Finances
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students. In 2017, Adtalem lost approximately $4.6 million from the impacts of Hurricane Irma and Hurricane Maria. The company made a profit of $95.6 million in 2019 and lost $85.8 million in 2020, suffering from enrollment declines during the COVID-19 pandemic. In early 2024, Adtalem was targeted by a short seller and the company announced a $300 million repurchase program. In late 2024, Investor's Business Daily said Adtalem saw an average sales growth of fourteen percent over the last three years. For the 2024 fiscal year, Adtalem repurchased 5.446 million shares for approximately $261 million. In May 2025, the repurchase was completed and a new stock buyback program of up to $150 million through May 2028 was launched.
Controversies
Covista, formerly known as DeVry Education Group, has been the subject of numerous investigations and lawsuits alleging that a variety of false or deceptive practices. While the group has generally denied the allegations, several cases led to multi-million dollar settlements.
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students.
Months after the FTC settlement, DeVry Education Group rebranded as Adtalem Global Education in May 2018. Adtalem rebranded as Covista in 2026.
For-profit higher education in the United States has been the subject of hearings by the United States Senate Committee on Health, Education, Labor, and Pensions. Specifically regarding DeVry, the Committee found that over half of the students enrolled at DeVry in 2008-2009 withdrew by mid-2010. As of 2015, DeVry spent more on marketing than on student instruction.
As of 2013, DeVry Inc. was under investigation by the Attorneys General of the states of Illinois and Massachusetts.
In 2014, accumulated student loan debt from DeVry University and Keller, its graduate school, had reached approximately $12.1 billion.
A lawsuit filed against DeVry alleged deceptive recruiting practices in violation of federal law.
In January 2016, The Federal Trade Commission filed a lawsuit against DeVry Education Group alleging false or misleading advertising. A class action lawsuit was also filed against DeVry Group in US District Court, Northern District of California claiming breaches of contract, good faith and fair dealing, violations of the California Unfair Trade Practices Act, the California False Advertising Act and the California Consumer Legal Remedies Act, and negligent misrepresentations. A confidential settlement was reached.
In May 2016, a shareholder class action lawsuit was filed against DeVry Group, in the US District Court, Northern District of Illinois. The plaintiffs claimed that defendants made false or misleading statements regarding DeVry University's graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. The case was settled in 2019 for $27.5 million.
In December 2017, a former administrator filed a civil lawsuit number with the Los Angeles Superior Court, seeking relief for a number of causes of action including Retaliation and Wrongful Termination in Violation of Public Policy for complaining about an incentive-based compensation program that rewarded campus deans for recruiting and enrolling students.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CVSA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 17.85-Jahres-Durchschnitt ≈18.8 | ≈18.8 | · | · | |
| P/S (TTM) | 2.25-Jahres-Durchschnitt ≈1.8 | ≈1.8 | · | · | |
| K/B (MRQ) | 3.05-Jahres-Durchschnitt ≈2.2 | ≈2.2 | · | · | |
| EV / EBITDA | 11.85-Jahres-Durchschnitt ≈12.8 | ≈12.8 | · | · | |
| Kurs / FCF (TTM) | 10.95-Jahres-Durchschnitt ≈11.5 | ≈11.5 | · | · | |
| Kurs / Cashflow (TTM) | 9.15-Jahres-Durchschnitt ≈9.6 | ≈9.6 | · | · | |
| EV / Revenue (EV / Umsatz) | 2.35-Jahres-Durchschnitt ≈2.1 | ≈2.1 | · | · | |
| EV / FCF | 11.55-Jahres-Durchschnitt ≈13.0 | ≈13.0 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 6.2 | · | · | · | |
| PEG Ratio (PEG-Ratio) | ≈0.5 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CVSA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 19.6%5-Jahres-Durchschnitt ≈16.0% | ≈16.0% | · | · | |
| EBITDA Margin (EBITDA-Marge) | 19.6%5-Jahres-Durchschnitt ≈16.0% | ≈16.0% | · | · | |
| Vorgewinnmarge (TTM) | 17.7%5-Jahres-Durchschnitt ≈13.1% | ≈13.1% | · | · | |
| Nettogewinnmarge (TTM) | 12.9%5-Jahres-Durchschnitt ≈10.3% | ≈10.3% | · | · | |
| ROA (TTM) | 8.7%5-Jahres-Durchschnitt ≈6.4% | ≈6.4% | · | · | |
| ROE (TTM) | 17.5%5-Jahres-Durchschnitt ≈12.7% | ≈12.7% | · | · | |
| ROIC | 14.1%5-Jahres-Durchschnitt ≈10.9% | ≈10.9% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CVSA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Debt / Equity (Fremdkapital / Eigenkapital) | 0.55-Jahres-Durchschnitt ≈0.4 | ≈0.4 | · | · | |
| Liquiditätsgrad (MRQ) | 1.15-Jahres-Durchschnitt ≈1.0 | ≈1.0 | · | · | |
| Quick Ratio | 1.05-Jahres-Durchschnitt ≈0.8 | ≈0.8 | · | · | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.55-Jahres-Durchschnitt ≈0.4 | ≈0.4 | · | · | |
| Interest Coverage (Zinsdeckungsgrad) | 8.45-Jahres-Durchschnitt ≈5.3 | ≈5.3 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CVSA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 9.3%5-Jahres-Durchschnitt ≈9.1% | ≈9.1% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 10.4%5-Jahres-Durchschnitt ≈14.7% | ≈14.7% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 16.8% | · | · | · | |
| EPS YoY (EPS VjV) | 13.9%5-Jahres-Durchschnitt ≈23.4% | ≈23.4% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 6.1%5-Jahres-Durchschnitt ≈14.0% | ≈14.0% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 50.9%5-Jahres-Durchschnitt ≈28.4% | ≈28.4% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 38.9% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 39.2%5-Jahres-Durchschnitt ≈18.5% | ≈18.5% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 29.1% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CVSA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.75-Jahres-Durchschnitt ≈0.6 | ≈0.6 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 12.65-Jahres-Durchschnitt ≈14.1 | ≈14.1 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$412.6K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Nov 30, 2016 | $0,18 | USD | ≈1.2% |
| Jun 1, 2016 | $0,18 | USD | ≈2.0% |
| Dez 2, 2015 | $0,18 | USD | ≈1.5% |
| Jun 3, 2015 | $0,18 | USD | ≈1.1% |
| Dez 3, 2014 | $0,18 | USD | ≈0.72% |
| Jun 4, 2014 | $0,17 | USD | ≈0.81% |
| Dez 4, 2013 | $0,17 | USD | ≈0.96% |
| Jun 5, 2013 | $0,17 | USD | ≈1.1% |
| Nov 28, 2012 | $0,17 | USD | ≈1.2% |
| Jun 19, 2012 | $0,15 | USD | ≈1.1% |
| Dez 6, 2011 | $0,15 | USD | ≈0.76% |
| Jun 16, 2011 | $0,12 | USD | ≈0.42% |
| Dez 8, 2010 | $0,12 | USD | ≈0.50% |
| Jun 11, 2010 | $0,10 | USD | ≈0.35% |
| Dez 9, 2009 | $0,10 | USD | ≈0.31% |
| Jun 12, 2009 | $0,08 | USD | ≈0.34% |
| Dez 10, 2008 | $0,08 | USD | ≈0.26% |
| Jun 17, 2008 | $0,06 | USD | ≈0.20% |
| Dez 12, 2007 | $0,06 | USD | ≈0.19% |
| Jun 14, 2007 | $0,05 | USD | ≈0.28% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | $2.09 | $1.93 | 8.3% | |
| 31. März 2026 | $1.98 | $1.76 | 12.7% | |
| 31. Dezember 2025 | $2.43 | $2.23 | 8.9% | |
| 30. September 2025 | $1.75 | $1.61 | 8.8% | |
| 30. Juni 2025 | $1.66 | $1.56 | 6.2% | |
| 31. März 2025 | $1.92 | $1.69 | 13.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Cost of Revenue | $834M | $771M | $699M | $648M | $660M | · | · | · | |
| SG&A Expense | $731M | $672M | $633M | $586M | $566M | · | · | · | |
| Operating Expenses | $1.57B | $1.45B | $1.37B | $1.28B | $1.31B | · | · | · | |
| Operating Income | $383M | $342M | $217M | $168M | $77M | · | · | · | |
| Interest Expense | $45M | $52M | $64M | $63M | $129M | · | · | · | |
| Interest Income | · | · | · | · | $4M | · | · | · | |
| Other Non-op | $7M | $9M | $11M | $7M | $1M | · | · | · | |
| Pretax Income | $345M | $299M | $164M | $112M | $-51M | · | · | · | |
| Income Tax | $78M | $66M | $26M | $10M | $-16M | · | · | · | |
| Net Income | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| EPS (Basic) | $7.18 | $6.39 | $3.47 | $2.08 | $6.43 | · | · | · | |
| EPS (Diluted) | $7.04 | $6.18 | $3.39 | $2.05 | $6.43 | · | · | · | |
| Shares (Basic) | 35,045,000 | 37,085,000 | 39,413,000 | 44,781,000 | 48,388,000 | · | · | · | |
| Shares (Diluted) | 35,715,000 | 38,334,000 | 40,307,000 | 45,600,000 | 48,388,000 | · | · | · | |
| EBITDA | $383M | $342M | $217M | $168M | $80M | · | · | · |
Bilanz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $200M | $219M | $272M | $347M | $275M | $416M | $67M | |
| Short-term Investments | · | · | · | · | · | · | · | $9M | |
| Receivables | $167M | $143M | $124M | $100M | $79M | $90M | $69M | · | |
| Prepaid Expense | $75M | $69M | $70M | $102M | $128M | $167M | $97M | $45M | |
| Current Assets | $652M | $416M | $418M | $480M | $557M | $611M | $681M | $390M | |
| PP&E (Net) | $303M | $256M | $249M | $245M | $290M | $302M | $279M | $282M | |
| PP&E (Gross) | $686M | $598M | $575M | $583M | $666M | $663M | $618M | $605M | |
| Accum. Depreciation | $383M | $342M | $326M | $339M | $376M | $362M | $339M | $323M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $960M | $310M | $687M | |
| Intangibles | $754M | $765M | $777M | $812M | $874M | $924M | $138M | $293M | |
| Other Non-current Assets | $138M | $129M | $103M | $81M | $119M | $118M | $88M | $83M | |
| Total Assets | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Accounts Payable | $125M | $105M | $103M | $82M | $57M | $65M | $39M | $31M | |
| Accrued Liabilities | $94M | $77M | $97M | $106M | $98M | $135M | $97M | $90M | |
| Current Liabilities | $597M | $508M | $488M | $431M | $424M | $497M | $341M | $304M | |
| Capital Leases | $208M | $186M | $168M | $163M | $177M | $156M | $194M | $180M | |
| Deferred Tax | $62M | $32M | $30M | $26M | $26M | $27M | $25M | $25M | |
| Other Non-current Liabilities | $42M | $40M | $39M | $37M | $74M | $58M | $81M | $89M | |
| Total Liabilities | $1.57B | $1.32B | $1.37B | $1.35B | $1.54B | $2.37B | $959M | $1.09B | |
| Long-term Debt | $663M | $553M | $649M | $695M | $839M | $1.61B | $287M | $415M | |
| Total Debt | $663M | $553M | $649M | $695M | $839M | · | · | · | |
| Common Stock | $848.0K | $839.0K | $832.0K | $822.0K | $818.0K | $817.0K | $810.0K | $806.0K | |
| Retained Earnings | $3.03B | $2.78B | $2.54B | $2.40B | $2.31B | $1.96B | $1.97B | $2.03B | |
| Treasury Stock | $2.29B | $2.01B | $1.78B | $1.51B | $1.34B | $1.22B | $1.16B | $1.08B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-634.0K | $-8M | $-159M | |
| Stockholders' Equity | $1.45B | $1.43B | $1.37B | $1.46B | $1.49B | $1.28B | $1.31B | $1.29B | |
| Liabilities + Equity | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Shares Outstanding | 34,033,000 | 35,952,000 | 37,681,000 | 82,232,000 | 81,796,000 | 81,705,000 | 81,021,000 | 52,953,000 |
Cashflow
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $42M | $26M | $14M | $23M | · | · | · | |
| Deferred Tax | $68M | $18M | $11M | $-5M | $-14M | · | · | · | |
| Amort. of Intangibles | $11M | $11M | $36M | $61M | $97M | · | · | · | |
| Restructuring | $6M | $3M | $2M | $19M | $26M | · | · | · | |
| Operating Cash Flow | $470M | $338M | $296M | $192M | $11M | · | · | · | |
| CapEx | $78M | $50M | $49M | $26M | $31M | · | · | · | |
| Investing Cash Flow | $-84M | $-42M | $-48M | $24M | $-552M | · | · | · | |
| Debt Issued | $1.01B | $10M | $2M | $0 | $850M | · | · | · | |
| Net Debt Issued | $112M | $-100M | $-50M | $-151M | $-230M | · | · | · | |
| Stock Repurchased | $240M | $213M | $262M | $123M | $120M | · | · | · | |
| Net Stock Activity | $-240M | $-213M | $-262M | $-123M | $-120M | · | · | · | |
| Financing Cash Flow | $-180M | $-316M | $-302M | $-289M | $-424M | · | · | · | |
| Net Change in Cash | $207M | $-20M | $-54M | $-73M | $-966M | · | · | · | |
| Taxes Paid | $14M | $33M | $31M | $12M | $94M | · | · | · | |
| Free Cash Flow | $393M | $288M | $247M | $166M | $-21M | · | · | · | |
| Levered FCF | $358M | $247M | $193M | $109M | $-106M | · | · | · |
Rentabilität
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| Net Margin | 12.9% | 13.3% | 8.6% | 6.4% | 22.9% | · | · | · | |
| Pretax Margin | 17.7% | 16.7% | 10.3% | 7.7% | -3.2% | · | · | · | |
| EBITDA Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| ROA | 8.7% | 8.6% | 4.9% | 3.3% | 9.7% | · | · | · | |
| ROE | 17.8% | 16.5% | 10.2% | 6.3% | 21.3% | · | · | · | |
| ROIC | 14.1% | 13.4% | 9.0% | 7.1% | 2.3% | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.8 | 0.9 | 1.1 | 1.3 | · | · | · | |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 0.9 | 1.0 | · | · | · | |
| Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| LT Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| Interest Coverage | 8.4 | 6.5 | 3.4 | 2.7 | 0.6 | · | · | · |
Effizienz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.6 | 0.5 | 0.4 | · | · | · | |
| Receivables Turnover | 12.6 | 13.4 | 14.1 | 16.2 | 16.1 | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $42.49 | $39.88 | $36.33 | $34.44 | $33.31 | · | · | · | |
| Revenue / Share | $54.71 | $46.65 | $39.31 | $31.82 | $28.67 | · | · | · | |
| Cash Flow / Share | $13.17 | $8.81 | $7.34 | $4.45 | $0.22 | · | · | · | |
| Cash / Share | $11.94 | $5.55 | $5.82 | $6.47 | $7.68 | · | · | · | |
| EPS (TTM) | $7.04 | $6.18 | $3.39 | $2.05 | $6.43 | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.8% | 9.2% | 5.0% | 53.7% | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 20.8% | 18.8% | · | · | · | · | |
| Revenue CAGR 5Y | 16.8% | 15.6% | · | · | · | · | · | · | |
| EPS YoY | 13.9% | 82.3% | 65.4% | -68.1% | 372.8% | · | · | · | |
| EPS CAGR 3Y | 50.9% | -1.3% | 35.6% | · | · | · | · | · | |
| EPS CAGR 5Y | 38.9% | · | · | · | · | · | · | · | |
| Net Income YoY | 6.1% | 73.3% | 46.5% | -70.0% | 344.1% | · | · | · | |
| Net Income CAGR 3Y | 39.2% | -8.6% | 25.0% | · | · | · | · | · | |
| Net Income CAGR 5Y | 29.1% | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Net Income TTM | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| Market Cap | $4.24B | $4.57B | $2.57B | $1.45B | $1.63B | · | · | · | |
| Enterprise Value | $4.50B | $4.93B | $3.00B | $1.87B | $2.12B | · | · | · | |
| P/E | 17.7 | 20.6 | 20.1 | 16.8 | 5.6 | · | · | · | |
| P/S | 2.2 | 2.6 | 1.6 | 1.0 | 1.2 | · | · | · | |
| P/B | 2.9 | 3.2 | 1.9 | 1.0 | 1.1 | · | · | · | |
| P / Cash Flow | 9.0 | 13.5 | 8.7 | 7.2 | 155.9 | · | · | · | |
| P / FCF | 10.8 | 15.9 | 10.4 | 8.8 | -78.8 | · | · | · | |
| EV / EBITDA | 11.7 | 14.4 | 13.8 | 11.1 | 26.3 | · | · | · | |
| EV / FCF | 11.5 | 17.1 | 12.2 | 11.3 | -102.6 | · | · | · | |
| EV / Revenue | 2.3 | 2.8 | 1.9 | 1.3 | 1.5 | · | · | · | |
| Earnings Yield | 5.7% | 4.9% | 5.0% | 6.0% | 17.9% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $501M | $487M | $503M | $462M | $457M | $466M | $448M | $417M | $410M | $413M | $393M | $369M | $365M | $369M | $363M | $354M | |
| Cost of Revenue | $217M | $211M | $205M | $201M | $199M | $200M | $187M | $186M | $183M | $175M | $172M | $169M | $164M | $166M | $159M | $160M | |
| SG&A Expense | $188M | $184M | $183M | $176M | $181M | $175M | $157M | $159M | $155M | $157M | $156M | $166M | $153M | $145M | $142M | $146M | |
| Operating Expenses | $406M | $396M | $392M | $377M | $380M | $376M | $344M | $347M | $341M | $351M | $335M | $341M | $325M | $310M | $317M | $331M | |
| Operating Income | $95M | $91M | $111M | $85M | $77M | $91M | $104M | $70M | $69M | $62M | $59M | $28M | $40M | $59M | $46M | $24M | |
| Interest Expense | $10M | $14M | $11M | $11M | $11M | $13M | $14M | $14M | $15M | $17M | $17M | $16M | $15M | $14M | $16M | $18M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | |
| Other Non-op | $3M | $232.0K | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $-1M | $761.0K | |
| Pretax Income | $88M | $78M | $102M | $77M | $69M | $79M | $92M | $58M | $56M | $48M | $45M | $15M | $28M | $49M | $29M | $7M | |
| Income Tax | $16M | $20M | $26M | $16M | $14M | $19M | $21M | $12M | $5M | $11M | $8M | $3M | $4M | $389.0K | $4M | $1M | |
| Net Income | $72M | $42M | $76M | $62M | $54M | $61M | $76M | $46M | $49M | $37M | $40M | $11M | $22M | $46M | $25M | $592.0K | |
| EPS (Basic) | $2.12 | $1.21 | $2.14 | $1.71 | $1.50 | $1.64 | $2.03 | $1.22 | $1.26 | $0.95 | $1.00 | $0.26 | $0.51 | $1.02 | $0.54 | $0.01 | |
| EPS (Diluted) | $2.06 | $1.20 | $2.11 | $1.67 | $1.43 | $1.59 | $1.98 | $1.18 | $1.23 | $0.93 | $0.98 | $0.25 | $0.51 | $1.00 | $0.53 | $0.01 | |
| Shares (Basic) | · | 34,283,000 | 35,725,000 | 36,111,000 | · | 37,140,000 | 37,435,000 | 37,721,000 | · | 38,713,000 | 39,872,000 | 41,399,000 | · | 45,125,000 | 45,425,000 | 45,274,000 | |
| Shares (Diluted) | · | 34,782,000 | 36,230,000 | 37,057,000 | · | 38,233,000 | 38,401,000 | 39,109,000 | · | 39,636,000 | 40,787,000 | 42,184,000 | · | 45,801,000 | 46,121,000 | 46,342,000 | |
| EBITDA | · | $91M | $111M | $85M | · | $91M | $104M | $70M | · | $62M | $59M | $28M | · | $59M | $46M | $23M |
Bilanz
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $147M | $56M | $265M | $200M | $219M | $194M | $265M | $219M | $180M | $183M | $262M | · | $315M | $208M | $328M | |
| Receivables | $167M | $173M | $160M | $192M | $143M | $160M | $144M | $169M | $124M | $138M | $131M | $145M | · | $111M | $97M | $109M | |
| Prepaid Expense | $75M | $79M | $81M | $106M | $69M | $66M | $65M | $79M | $70M | $59M | $58M | $61M | · | $103M | $114M | $128M | |
| Current Assets | $652M | $404M | $303M | $567M | $416M | $450M | $407M | $517M | $418M | $388M | $378M | $473M | · | $533M | $423M | $570M | |
| PP&E (Net) | $303M | $277M | $266M | $257M | $256M | $251M | $246M | $245M | $249M | $273M | $260M | $265M | · | $253M | $276M | $282M | |
| PP&E (Gross) | $686M | $649M | $627M | $608M | $598M | $583M | $583M | $574M | $575M | $600M | $605M | $609M | · | $583M | $621M | $646M | |
| Accum. Depreciation | $383M | $372M | $361M | $351M | $342M | $332M | $337M | $329M | $326M | $327M | $345M | $345M | · | $330M | $346M | $364M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | · | $961M | $961M | $961M | |
| Intangibles | $754M | $757M | $760M | $763M | $765M | $768M | $771M | $774M | $777M | $784M | $792M | $802M | · | $825M | $839M | $855M | |
| Other Non-current Assets | $138M | $137M | $135M | $129M | $129M | $120M | $113M | $108M | $103M | $68M | $66M | $68M | · | $68M | $117M | $121M | |
| Total Assets | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Accounts Payable | $125M | $97M | $103M | $105M | $105M | $99M | $67M | $91M | $103M | $92M | $88M | $77M | · | $73M | $71M | $64M | |
| Accrued Liabilities | $94M | $93M | $72M | $63M | $77M | $86M | $62M | $87M | $97M | $114M | $98M | $89M | · | $87M | $94M | $94M | |
| Current Liabilities | $597M | $580M | $443M | $577M | $508M | $541M | $385M | $551M | $488M | $509M | $399M | $496M | · | $438M | $371M | $491M | |
| Capital Leases | $208M | $202M | $191M | $188M | $186M | $193M | $182M | $162M | $168M | $160M | $169M | $161M | · | $164M | $166M | $165M | |
| Deferred Tax | $62M | $59M | $57M | $53M | $32M | $34M | $32M | $30M | $30M | $29M | $27M | $26M | · | $27M | $27M | $26M | |
| Other Non-current Liabilities | $42M | $37M | $41M | $38M | $40M | $37M | $35M | $35M | $39M | $48M | $41M | $37M | · | $33M | $62M | $63M | |
| Total Liabilities | $1.57B | $1.37B | $1.24B | $1.41B | $1.32B | $1.36B | $1.28B | $1.43B | $1.37B | $1.39B | $1.33B | $1.42B | · | $1.36B | $1.32B | $1.49B | |
| Long-term Debt | $663M | $499M | $504M | $553M | $553M | $552M | $650M | $649M | $649M | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Total Debt | · | $499M | $504M | $553M | · | $552M | $650M | $649M | · | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Common Stock | $848.0K | $847.0K | $847.0K | $847.0K | $839.0K | $839.0K | $839.0K | $838.0K | $832.0K | $831.0K | $831.0K | $826.0K | · | $822.0K | $822.0K | $821.0K | |
| Retained Earnings | $3.03B | $2.96B | $2.92B | $2.84B | $2.78B | $2.72B | $2.66B | $2.59B | $2.54B | $2.49B | $2.45B | $2.41B | · | $2.38B | $2.35B | $2.33B | |
| Treasury Stock | $2.29B | $2.29B | $2.22B | $2.05B | $2.01B | $1.94B | $1.87B | $1.83B | $1.78B | $1.77B | $1.68B | $1.61B | · | $1.43B | $1.39B | $1.34B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $1.45B | $1.36B | $1.38B | $1.46B | $1.43B | $1.43B | $1.44B | $1.39B | $1.37B | $1.32B | $1.37B | $1.38B | $1.46B | $1.51B | $1.52B | $1.51B | |
| Liabilities + Equity | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Shares Outstanding | 34,033,000 | 34,023,000 | 34,654,000 | 36,324,000 | 35,952,000 | 36,512,000 | 37,289,000 | 37,716,000 | 37,681,000 | 37,765,000 | 39,526,000 | 40,401,000 | 82,232,000 | 44,232,000 | 45,443,000 | 45,396,000 |
Cashflow
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $10M | $13M | $8M | $10M | $10M | $11M | $9M | $7M | $6M | $6M | $7M | $3M | $3M | $2M | $6M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $7M | $8M | $9M | $11M | $12M | $14M | $16M | $19M | |
| Restructuring | $1M | $863.0K | $4M | $310.0K | $388.0K | $510.0K | $322.0K | $2M | $653.0K | $473.0K | $68.0K | $676.0K | $1M | $1M | $1M | $15M | |
| Operating Cash Flow | $124M | $186M | $30M | $131M | $60M | $208M | $-19M | $89M | $60M | $143M | $-18M | $95M | $42M | $108M | $-50M | $91M | |
| CapEx | $27M | $20M | $15M | $16M | $19M | $10M | $11M | $10M | $17M | $2M | $5M | $10M | $7M | $9M | $4M | $5M | |
| Investing Cash Flow | $-28M | $-20M | $-20M | $-16M | $-12M | $-10M | $-11M | $-10M | $-16M | $-2M | $-5M | $-10M | $-7M | $44M | $-7M | $-6M | |
| Debt Issued | $163M | $617M | · | · | $0 | $0 | $0 | $10M | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | · | · | · | $0 | · | · | · | $-101M | |
| Stock Repurchased | $0 | $68M | $165M | $8M | $67M | $72M | $41M | $33M | $12M | $90M | $70M | $90M | $78M | · | · | $0 | |
| Net Stock Activity | · | · | · | $-8M | · | · | · | $-33M | · | · | · | $-90M | · | · | · | · | |
| Financing Cash Flow | $163M | $-76M | $-218M | $-50M | $-68M | $-172M | $-42M | $-34M | $-11M | $-140M | $-56M | $-95M | $-78M | $-44M | $-63M | $-103M | |
| Net Change in Cash | $259M | $90M | $-208M | $65M | $-20M | $26M | $-71M | $46M | $34M | $1M | $-78M | $-11M | $-42M | $107M | $-120M | $-18M | |
| Free Cash Flow | · | · | · | $115M | · | · | · | $79M | · | · | · | $85M | · | · | · | $86M | |
| Levered FCF | · | · | · | $106M | · | · | · | $67M | · | · | · | $72M | · | · | · | $71M |
Rentabilität
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| Net Margin | · | 8.6% | 15.2% | 13.4% | · | 13.1% | 16.9% | 11.1% | · | 8.9% | 10.1% | 2.9% | · | 12.4% | 6.7% | 0.62% | |
| Pretax Margin | · | 16.0% | 20.2% | 16.6% | · | 17.0% | 20.6% | 14.0% | · | 11.6% | 11.6% | 4.0% | · | 13.3% | 7.7% | 1.9% | |
| EBITDA Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| ROA | · | 1.5% | 2.9% | 2.2% | · | 2.2% | 2.8% | 1.7% | · | 1.3% | 1.4% | 0.37% | · | 1.4% | 0.74% | 0.06% | |
| ROE | · | 3.0% | 5.4% | 4.3% | · | 4.4% | 5.4% | 3.3% | · | 2.6% | 2.8% | 0.74% | · | 3.1% | 1.7% | 0.16% | |
| ROIC | · | 3.6% | 4.4% | 3.4% | · | 3.5% | 3.8% | 2.7% | · | 2.4% | 2.4% | 1.1% | · | 2.7% | 1.8% | 0.87% |
Liquidität & Solvenz
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.7 | 0.7 | 1.0 | · | 0.8 | 1.1 | 0.9 | · | 0.8 | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.2 | |
| Quick Ratio | · | 0.6 | 0.5 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 0.6 | 0.8 | 0.8 | · | 1.0 | 0.8 | 0.9 | |
| Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| LT Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | 6.7 | 10.2 | 7.7 | · | 6.9 | 7.5 | 4.8 | · | 3.7 | 3.5 | 1.8 | · | 4.1 | 3.0 | 1.3 |
Effizienz
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | · | 2.9 | 3.3 | 2.6 | · | 3.1 | 3.3 | 2.7 | · | 3.3 | 3.4 | 2.9 | · | 3.6 | 3.9 | 2.6 |
Pro Aktie
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $40.09 | $39.79 | $40.13 | · | $39.24 | $38.59 | $36.85 | · | $34.98 | $34.65 | $34.12 | · | $34.15 | $33.51 | $33.26 | |
| Revenue / Share | · | $14.00 | $13.89 | $12.48 | · | $12.19 | $11.66 | $10.67 | · | $10.41 | $9.64 | $8.74 | · | $8.06 | $7.88 | $7.65 | |
| Cash Flow / Share | · | · | · | $3.52 | · | · | · | $2.28 | · | · | · | $2.36 | · | · | · | $1.97 | |
| Cash / Share | · | $4.32 | $1.62 | $7.29 | · | $6.00 | $5.20 | $7.02 | · | $4.76 | $4.63 | $6.50 | · | $7.13 | $4.57 | $7.21 | |
| EPS (TTM) | · | $6.41 | $6.80 | $6.67 | · | $5.98 | $5.32 | $4.32 | · | $2.67 | $2.74 | $2.29 | · | $1.74 | $7.78 | $7.61 |
Bewertung (TTM)
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $1.91B | $1.89B | $1.83B | · | $1.74B | $1.69B | $1.63B | · | $1.54B | $1.50B | $1.47B | · | $1.44B | $1.44B | $1.45B | |
| Net Income TTM | · | $234M | $253M | $253M | · | $232M | $208M | $172M | · | $110M | $119M | $103M | · | $75M | $376M | $370M | |
| Market Cap | · | $3.92B | $3.59B | $5.61B | · | $3.67B | $3.39B | $2.85B | · | $1.94B | $2.33B | $1.73B | · | $1.71B | $1.61B | $1.65B | |
| Enterprise Value | · | $4.27B | $4.03B | $5.90B | · | $4.01B | $3.84B | $3.23B | · | $2.41B | $2.84B | $2.16B | · | $2.09B | $2.10B | $2.07B | |
| P/E | · | 18.0 | 15.2 | 23.2 | · | 16.8 | 17.1 | 17.5 | · | 19.3 | 21.5 | 18.7 | · | 22.2 | 4.6 | 4.8 | |
| P/S | · | 2.1 | 1.9 | 3.1 | · | 2.1 | 2.0 | 1.7 | · | 1.3 | 1.6 | 1.2 | · | 1.2 | 1.1 | 1.1 | |
| P/B | · | 2.9 | 2.6 | 3.8 | · | 2.6 | 2.4 | 2.0 | · | 1.5 | 1.7 | 1.3 | · | 1.1 | 1.1 | 1.1 | |
| P / Cash Flow | · | · | · | 43.0 | · | · | · | 31.9 | · | · | · | 17.4 | · | · | · | 18.1 | |
| EV / Revenue | · | 2.2 | 2.1 | 3.2 | · | 2.3 | 2.3 | 2.0 | · | 1.6 | 1.9 | 1.5 | · | 1.4 | 1.5 | 1.4 | |
| Earnings Yield | · | 5.6% | 6.6% | 4.3% | · | 5.9% | 5.9% | 5.7% | · | 5.2% | 4.7% | 5.3% | · | 4.5% | 21.9% | 20.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Umsatz | $1.95B | $1.79B | $1.58B | $1.45B | · |
| Betriebsgewinnmarge % | 19.6% | 19.1% | 13.7% | 11.6% | · |
| Nettoergebnis | $252M | $237M | $137M | $93M | · |
| Verwässerte EPS | $7.04 | $6.18 | $3.39 | $2.05 | · |
| Kennzahl | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.5 | 0.4 | 0.5 | 0.5 | · |
| Liquiditätsgrad | 1.1 | 0.8 | 0.9 | 1.1 | · |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 0.9 | · |
| Kennzahl | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $393M | $288M | $247M | $166M | · |
Institutionelle Eigentümer (13F) 399 Einreicher · $4.5B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 53 (0 vs. Vorquartal) | 30 (-22 vs. Vorquartal) | 142 (+2 vs. Vorquartal) | 135 (+4 vs. Vorquartal) | -171K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $683.177.439 | 5.480.326 | 15,10% | Aktien |
| VANGUARD GROUP INC | $449.985.960 | 4.348.951 | 9,94% | Aktien |
| FMR LLC | $401.181.165 | 3.218.203 | 8,87% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $297.558.184 | 2.386.958 | 6,58% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $222.235.571 | 1.782.750 | 4,91% | Aktien |
| ARIEL INVESTMENTS, LLC | $220.878.073 | 1.771.844 | 4,88% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $183.742.358 | 1.473.948 | 4,06% | Aktien |
| STATE STREET CORP | $173.212.203 | 1.389.477 | 3,83% | Aktien |
| Capital World Investors | $132.593.736 | 1.063.643 | 2,93% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $111.498.699 | 894.257 | 2,46% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $99.984.176 | 802.055 | 2,21% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $78.581.301 | 630.365 | 1,74% | Aktien |
| Boston Partners | $71.229.785 | 567.172 | 1,57% | Aktien |
| FRANKLIN RESOURCES INC | $70.714.009 | 567.255 | 1,56% | Aktien |
| Alyeska Investment Group, L.P. | $68.807.458 | 551.961 | 1,52% | Aktien |
| Fisher Asset Management, LLC | $63.050.035 | 505.776 | 1,39% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.245.186 | 483.276 | 1,33% | Aktien |
| MORGAN STANLEY | $58.961.768 | 472.980 | 1,30% | Aktien |
| NORTHERN TRUST CORP | $54.225.605 | 434.988 | 1,20% | Aktien |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | $44.010.839 | 353.047 | 0,97% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $37.728.848 | 302.654 | 0,83% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $33.376.692 | 271.952 | 0,74% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $32.342.164 | 259.443 | 0,71% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $30.437.360 | 244.163 | 0,67% | Aktien |
| Bank of New York Mellon Corp | $28.712.585 | 230.327 | 0,63% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $26.394.013 | 211.728 | 0,58% | Aktien |
| Allianz Asset Management GmbH | $24.804.472 | 198.977 | 0,55% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $24.151.629 | 193.740 | 0,53% | Aktien |
| Nuveen, LLC | $23.937.712 | 192.024 | 0,53% | Aktien |
| SG Capital Management LLC | $22.238.845 | 178.396 | 0,49% | Aktien |
| BANK OF AMERICA CORP /DE/ | $21.978.929 | 176.311 | 0,49% | Aktien |
| GOLDMAN SACHS GROUP INC | $20.337.780 | 163.146 | 0,45% | Aktien |
| TWO SIGMA ADVISERS, LP | $19.876.587 | 192.100 | 0,44% | Aktien |
| ALGERT GLOBAL LLC | $19.323.048 | 155.006 | 0,43% | Aktien |
| Invesco Ltd. | $18.361.795 | 147.295 | 0,41% | Aktien |
| Public Sector Pension Investment Board | $17.393.810 | 139.530 | 0,38% | Aktien |
| Corient Private Wealth LP | $17.190.989 | 137.903 | 0,38% | Aktien |
| PRUDENTIAL FINANCIAL INC | $15.911.852 | 127.642 | 0,35% | Aktien |
| WESTPORT ASSET MANAGEMENT INC | $15.677.117 | 125.759 | 0,35% | Aktien |
| MACKENZIE FINANCIAL CORP | $13.510.152 | 108.376 | 0,30% | Aktien |
| WELLS FARGO & COMPANY/MN | $12.758.571 | 102.347 | 0,28% | Aktien |
| Qube Research & Technologies Ltd | $12.647.380 | 101.455 | 0,28% | Aktien |
| RHUMBLINE ADVISERS | $10.647.181 | 85.410 | 0,24% | Aktien |
| Legal & General Group Plc | $10.482.784 | 84.091 | 0,23% | Aktien |
| LGT CAPITAL PARTNERS LTD. | $10.035.130 | 80.500 | 0,22% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $9.671.247 | 77.581 | 0,21% | Aktien |
| Foresight Group Ltd Liability Partnership | $9.636.366 | 77.264 | 0,21% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $9.436.388 | 75.697 | 0,21% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $8.879.782 | 77.048 | 0,20% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $8.696.157 | 69.759 | 0,19% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| International Value Advisers, LLC, Charles de Vaulx ×18 Einreichungen | 7. August 2020 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 113 Insider · 51 Führungskräfte · 26 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Stephen W. Beard, | Chairman & CEO | 23. August 2026 F | 477.464 | 0 | 5 | $-3.938.087 |
| Daniel Hamburger | President and CEO | 31. August 2015 S | 142.136 | 0 | 0 | $0 |
| Robert J. Phelan | Chief Financial Officer | 23. August 2026 F | 56.571 | 0 | 4 | $-2.277.058 |
| Michael O Randolfi | SVP, Chief Financial Officer | 28. August 2020 F | 84.391 | 0 | 0 | $0 |
| Timothy J Wiggins | SVP & Chief Financial Officer | 25. Februar 2016 S | 44.939 | 0 | 0 | $0 |
| Richard Gunst | Chief Financial Officer | 1. Februar 2012 M | 9.356 | 0 | 0 | $0 |
| Amelia Manning | President, Chamberlain Univ. | 15. Juli 2026 A | 4.317 | 0 | 0 | $0 |
| Karen Sue Cox | President, Chamberlain Univ. | 8. Mai 2026 S | 31.596 | 0 | 1 | $-249.000 |
| Scott Liles | President, Medical and Vet | 15. April 2026 F | 13.103 | 0 | 0 | $0 |
| Evan Trent | President, Adtalem Elevate | 13. November 2025 F | 24.134 | 0 | 0 | $0 |
| Thiago Aguiar Sayao | Group President, Business &Law | 28. Februar 2020 S | 1.830 | 0 | 0 | $0 |
| Carlos Filgueiras | Group President, Tech/Business | 13. Februar 2019 S | 11.775 | 0 | 0 | $0 |
| Donna M Loraine | President, Carrington Colleges | 6. November 2018 M | 6.701 | 0 | 0 | $0 |
| Susan Groenwald | President, Chamberlain | 9. Februar 2018 M | 34.402 | 0 | 0 | $0 |
| John P Roselli | President, Becker Professional | 1. September 2017 S | 13.730 | 0 | 0 | $0 |
| Eric P. Dirst | President, ATGE Shared Ops | 31. August 2017 S | 14.800 | 0 | 0 | $0 |
| Robert A Paul | President, DeVry University | 25. August 2017 M | 28.426 | 0 | 0 | $0 |
| Steven Riehs | President, Med, Prof & Online | 2. September 2016 M | 28.062 | 0 | 0 | $0 |
| Jeffrey Richard Akens | President, Carrington College | 29. August 2015 F | 6.752 | 0 | 0 | $0 |
| Christopher Caywood | President, Online Services | 1. März 2013 F | 7.378 | 0 | 0 | $0 |
| Andrew A Jeon | President, DeVry Medical Int'l | 2. November 2012 F | 5.655 | 0 | 0 | $0 |
| William B. Hughson | President, Medical & | 29. August 2012 A | 2.143 | 0 | 0 | $0 |
| George Montgomery | President, U.S. Education | 27. August 2010 A | · | 0 | 0 | $0 |
| Manjunath Gangadharan | VP, Chief Accounting Officer | 27. August 2026 S | 5.083 | 0 | 1 | $-247.198 |
| Michael Betz | Pres. Walden University & CDO | 23. August 2026 F | 39.172 | 0 | 0 | $0 |
| Douglas G. Beck | SVP, GC, Corp. Sec & ISS | 23. August 2026 F | 33.394 | 0 | 4 | $-2.524.973 |
| Maurice Herrera | SVP - Chief Marketing Officer | 13. November 2025 F | 20.584 | 0 | 0 | $0 |
| Megan Noel | Chief Corp. Affairs Officer | 12. November 2025 A | 2.226 | 0 | 0 | $0 |
| Sara Hill | CHRO | 12. November 2025 A | 10.276 | 0 | 0 | $0 |
| Blake Simpson | SVP, Chief Comms & CA Officer | 5. Dezember 2024 F | 8.795 | 0 | 0 | $0 |
| Steven Tom | SVP Chief Customer Officer | 13. November 2024 A | 13.255 | 0 | 0 | $0 |
| Cheryl James | SVP, CHRO | 28. Februar 2024 F | 17.485 | 0 | 0 | $0 |
| John W Danaher MD | Pres. - Adtalem Med & Vet | 25. August 2023 F | 38.718 | 0 | 0 | $0 |
| James Raymond Bartholomew | SVP - Chamberlain University | 26. August 2022 F | 6.418 | 0 | 0 | $0 |
| Holland Katherine Alice Boden | Group Pres, Adtalem Health | 30. August 2021 F | 32.148 | 0 | 0 | $0 |
| Fernando Lau | SVP, Chief Marketing Officer | 28. August 2021 F | 19.253 | 0 | 0 | $0 |
| Christopher C Nash | SVP, Chief Information Officer | 28. August 2021 F | 25.741 | 0 | 0 | $0 |
| Donna Jennings | SVP, Human Resources | 28. August 2021 F | 30.898 | 0 | 0 | $0 |
| Chaka M Patterson | SVP and General Counsel | 28. August 2020 F | 5.202 | 0 | 0 | $0 |
| Mehul R Patel | Group Pres, Financial Services | 7. November 2019 F | 11.258 | 0 | 0 | $0 |
| Kathleen Carroll | Vice President, Controller | 28. August 2019 A | 5.497 | 0 | 0 | $0 |
| Lisa M Sodeika | SVP, Corporate Affairs | 28. August 2019 A | 24.151 | 0 | 0 | $0 |
| Patrick J Unzicker | Principal Financial Officer | 27. August 2019 F | 36.360 | 0 | 0 | $0 |
| Catherine C. Anderson | SVP, Strategy & Innovation | 26. August 2019 F | 6.025 | 0 | 0 | $0 |
| Gena L Ashe | SVP, CLO and Secretary | 23. August 2017 A | 4.420 | 0 | 0 | $0 |
| Gregory S Davis | SVP and General Counsel | 1. September 2016 S | 22.433 | 0 | 0 | $0 |
| Adriano Allegrini | VP, Strategy and Bus. Develop. | 29. August 2015 F | 7.004 | 0 | 0 | $0 |
| Sharon Thomas Parrott | SVP, Gov. & Regulatory Affairs | 5. November 2014 A | 5.610 | 0 | 0 | $0 |
| David J Pauldine | Executive Vice President & | 25. April 2014 M | 30.242 | 0 | 0 | $0 |
| Thomas C Shepherd | Executive Vice President and | 27. Mai 2011 M | 0 | 0 | 0 | $0 |
| Thomas J Vucinic | Sr. Vice President & President | 27. August 2010 A | 258 | 0 | 0 | $0 |
| Michael W Malafronte | Direktor | 31. August 2026 G | 110.705 | 5 | 0 | $3.844.716 |
| William V Krehbiel | Direktor | 13. November 2025 F | 16.303 | 0 | 0 | $0 |
| Betty M. Vandenbosch | Direktor | 13. November 2025 F | 2.584 | 0 | 0 | $0 |
| Kenneth J Phelan | Direktor | 13. November 2025 F | 19.836 | 1 | 0 | $49.931 |
| Georgette D. Kiser | Direktor | 13. November 2025 F | 17.481 | 0 | 0 | $0 |
| Lisa W Wardell | Direktor | 13. November 2025 F | 44.251 | 0 | 0 | $0 |
| Donna J Hrinak | Direktor | 13. November 2025 F | 8.218 | 0 | 0 | $0 |
| William W Burke | Direktor | 13. November 2025 F | 10.423 | 0 | 0 | $0 |
| Sharon O'Keefe | Direktor | 12. November 2025 A | 16.597 | 0 | 0 | $0 |
| Mayur Gupta | Direktor | 8. November 2024 F | 6.667 | 0 | 0 | $0 |
| Charles Deshazer | Direktor | 9. November 2023 F | 5.132 | 0 | 0 | $0 |
| James D White | Direktor | 11. Februar 2021 P | 13.152 | 0 | 0 | $0 |
| Steven Altschuler | Direktor | 6. November 2019 A | 6.170 | 0 | 0 | $0 |
| Ann Hart | Direktor | 8. November 2018 F | 7.117 | 0 | 0 | $0 |
| Fernando Ruiz | Direktor | 10. November 2016 A | 16.956 | 0 | 0 | $0 |
| David S Brown | Direktor | 5. November 2016 F | 5.182 | 0 | 0 | $0 |
| Alan G Merten | Direktor | 5. November 2016 F | 9.302 | 0 | 0 | $0 |
| Connie R Curran | Direktor | 7. November 2014 F | 13.295 | 0 | 0 | $0 |
| Darren Richard Huston | Direktor | 7. Juli 2014 F | 10.436 | 0 | 0 | $0 |
| William T Keevan | Direktor | 10. November 2013 F | 15.041 | 0 | 0 | $0 |
| Julie A Mcgee | Direktor | 10. November 2013 F | 24.542 | 0 | 0 | $0 |
| Harold T Shapiro | Direktor | 3. November 2013 F | 8.879 | 0 | 0 | $0 |
| Gary C Butler | Direktor | 3. November 2012 F | 4.275 | 0 | 0 | $0 |
| MICROSOFT CORP | Direktor | 10. November 2009 A | 1.290 | 0 | 0 | $0 |
| KREHBIEL FREDERICK A | Direktor | 29. Oktober 2008 S | 1.700 | 0 | 0 | $0 |
| Dennis J Keller | 10%-Eigentümer | 25. August 2010 G | 5.760.787 | 0 | 0 | $0 |
| Lyle Logan | · | 8. November 2022 S | 27.048 | 0 | 0 | $0 |
| Ronald L Taylor | · | 8. November 2018 F | 424.605 | 0 | 0 | $0 |
| Christopher B Begley | · | 10. November 2016 A | 15.057 | 0 | 0 | $0 |
| Charles A Bowsher | · | 29. Januar 2008 M | 2 | 0 | 0 | $0 |
| Harvey Leffring | · | 7. November 2007 A | · | 0 | 0 | $0 |
| Patrick L Mayers | · | 30. Oktober 2007 S | 2.500 | 0 | 0 | $0 |
| Paul E. Eppen | · | 29. Oktober 2007 M | 7.477 | 0 | 0 | $0 |
| Robert C Mccormack | · | 29. Oktober 2007 M | 1.784 | 0 | 0 | $0 |
| Norman M Levine | · | 17. August 2007 S | 10.500 | 0 | 0 | $0 |
| Kenneth Rutkowski | · | 9. Februar 2007 M | 7.514 | 0 | 0 | $0 |
| John O Skubiak | · | 8. Februar 2007 G | 29.575 | 0 | 0 | $0 |
| Rose Marie Dishman | · | 8. Februar 2007 S | 0 | 0 | 0 | $0 |
| Jack Calabro | · | 31. Januar 2007 S | 0 | 0 | 0 | $0 |
| John M Holbrook | · | 3. Oktober 2006 A | · | 0 | 0 | $0 |
| Robert C Le Valley | · | 3. Oktober 2006 A | 0 | 0 | 0 | $0 |
| Gerald A Murphy | · | 3. Oktober 2006 A | 3.125 | 0 | 0 | $0 |
| James W Kho | · | 3. Oktober 2006 A | · | 0 | 0 | $0 |
| Galen Graham | · | 3. Oktober 2006 A | 489 | 0 | 0 | $0 |
| James A Dugan | · | 3. Oktober 2006 A | 0 | 0 | 0 | $0 |
| Jerry R Dill | · | 3. Oktober 2006 A | 400 | 0 | 0 | $0 |
| Thomas Babel | · | 3. Oktober 2006 A | · | 0 | 0 | $0 |
| Timothy H Ricordati | · | 13. September 2006 M | 12.400 | 0 | 0 | $0 |
| Timothy J Joyce | · | 22. Dezember 2005 S | 2.534 | 0 | 0 | $0 |
| Gerald J Wawrzynek | · | 8. Dezember 2005 M | 5.500 | 0 | 0 | $0 |
| George W Fisher | · | 16. November 2005 M | 1.640 | 0 | 0 | $0 |
| Marilynn J Cason | · | 26. August 2005 G | 8.961 | 0 | 0 | $0 |
| Fredric M Weber | · | 25. Mai 2005 M | 1.000 | 0 | 0 | $0 |
| Hugo J Melvoin | · | 29. April 2005 G | 7.412 | 0 | 0 | $0 |
| David M Webster | · | 27. April 2005 A | · | 0 | 0 | $0 |
| Edward J Steffes | · | 27. April 2005 S | 0 | 0 | 0 | $0 |
| Thurston E Manning | · | 15. Februar 2005 S | 27.450 | 0 | 0 | $0 |
| Michael J Alexander | · | 10. August 2004 A | · | 0 | 0 | $0 |
| Bruno R Lacaria | · | 10. August 2004 A | · | 0 | 0 | $0 |
| Cecil Horst | · | 10. August 2004 A | 2.025 | 0 | 0 | $0 |
| Ronald Baron | · | 20. August 2003 S | 58.898 | 0 | 0 | $0 |
| Timothy E Foster | · | 15. August 2003 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 61 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PSCD · Invesco Exchange-Traded Fund Trust … | 1,87% | 3.441 SH | 1. Oktober 2026 | Täglich |
| PSL · Invesco Exchange-Traded Fund Trust | 1,66% | 10.434 SH | 1. Oktober 2026 | Täglich |
| CAFG · Pacer Funds Trust | 1,07% | 2.587 NS | 31. Juli 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 1,03% | 29.835 NS | 31. Juli 2026 | N-PORT |
| MYLD · Cambria ETF Trust | 0,95% | 2.595 NS | 31. Juli 2026 | N-PORT |
| XSHQ · Invesco Exchange-Traded Fund Trust … | 0,90% | 21.068 SH | 1. Oktober 2026 | Täglich |
| RZG · Invesco Exchange-Traded Fund Trust | 0,86% | 8.402 SH | 1. Oktober 2026 | Täglich |
| JSMD · Janus Detroit Street Trust | 0,74% | 62.173 NS | 31. Juli 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,46% | 40.509 SH | 19. August 2026 | Täglich |
| SMDX · Tidal Trust III | 0,34% | 3.536 NS | 31. Juli 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,32% | 33.449 NS | 31. Juli 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,28% | 5.402 SH | 1. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,28% | 323.692 SH | 11. September 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,27% | 28.163 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,25% | 36.861 SH | 19. August 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,23% | 119.030 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,23% | 50.636 SH | 1. Oktober 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 10.374 NS | 31. Juli 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,20% | 230.892 NS | 31. Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,20% | 4.269 SH | 1. Oktober 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,19% | 1.310 NS | 31. Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 9.079 NS | 31. Juli 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,15% | 30.619 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,14% | 882.577 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,14% | 16.493 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,14% | 10.597 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,13% | 198.216 SH | 19. August 2026 | Täglich |
| FDIS · FIDELITY COVINGTON TRUST | 0,13% | 17.290 NS | 31. Juli 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,12% | 19.657 SH | 1. Oktober 2026 | Täglich |
| VFQY · VANGUARD WELLINGTON FUND | 0,12% | 4.599 SH | 19. August 2026 | Täglich |
| VCR · VANGUARD WORLD FUND | 0,12% | 67.714 SH | 19. August 2026 | Täglich |
| PKW · Invesco Exchange-Traded Fund Trust | 0,11% | 14.767 SH | 1. Oktober 2026 | Täglich |
| VFMF · VANGUARD WELLINGTON FUND | 0,10% | 5.421 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,09% | 111.792 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,09% | 470.701 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,07% | 16.800 SH | 11. September 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,06% | 6.997 NS | 31. Juli 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 2.549 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,05% | 390.261 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,05% | 741.686 SH | 19. August 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,04% | 27.984 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,04% | 1.783 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,04% | 2.071 SH | 11. September 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,02% | 30.155 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 91.061 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 3.775 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 3.622 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 2.106 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1.024.746 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 2.840 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,01% | 7.618 SH | 19. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,01% | 7.798 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 10.330 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 44.952 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 9.317 SH | 11. September 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 25.773 SH | 19. August 2026 | Täglich |
| IJR · iShares Trust | · | 2.076.826 SH | 10. September 2026 | Täglich |
| IJT · iShares Trust | · | 321.953 SH | 9. September 2026 | Täglich |
| XJR · iShares Trust | · | 4.693 SH | 31. August 2026 | Täglich |
| ISCB · iShares Trust | · | 1.501 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 41.983 SH | 11. September 2026 | Täglich |
CVSA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
12-Monats-Kursziel
4 Analysten · 2026-09-29Mittelwert-Ziel $159.50 +27,1%
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CVSA | $4.24B | 17.7 | 9.3% | 12.9% | 17.8% | · |
| DUOL | $8.18B | 20.5 | 38.7% | 39.9% | 35.6% | 72.2% |
| LAUR | $4.81B | 17.8 | 8.6% | 16.6% | 26.2% | · |
| GHC | · | 16.5 | 2.5% | 5.9% | 6.5% | · |
| LOPE | $4.56B | 21.6 | 7.1% | 19.5% | 28.3% | · |
| LRN | $3.58B | 12.1 | 4.7% | 13.4% | 21.3% | 37.8% |
| BFAM | $5.64B | 30.2 | 9.2% | 6.6% | 14.1% | 23.8% |
| MH | $2.62B | 72.1 | 0.07% | 1.7% | 4.6% | 80.9% |
| PRDO | $1.83B | 12.1 | 24.2% | 18.9% | 16.3% | · |
| STRA | $1.84B | 14.8 | 4.0% | 10.0% | 7.6% | · |
| COUR | · | -23.7 | 9.0% | · | · | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.